Instalab

Vitamin D (1,25-dihydroxy) Test Blood

See whether your kidneys are properly activating vitamin D, a blind spot that standard vitamin D testing misses.

Should you take a Calcitriol test?

This test is most useful if any of these apply to you.

Already Managing Kidney Issues
Shows whether your kidneys are still converting vitamin D into its active form, a function that fades as kidney disease progresses.
Losing Bone Despite Normal Vitamin D
If your standard vitamin D looks fine but bones are thinning, this test checks whether the activation step is the missing piece.
Healthy but Want the Full Picture
Your standard vitamin D test shows stores. This one shows whether your body is turning those stores into the hormone your cells use.
Dealing With Abnormal Calcium or PTH
Calcitriol sits at the center of calcium regulation. Measuring it helps identify whether a parathyroid or kidney problem is at play.

About Vitamin D (1,25-dihydroxy)

Your standard vitamin D test measures the storage form of the vitamin circulating in your blood. But that storage form has to be converted into a hormone before it can do anything, and that conversion happens primarily in your kidneys. This test measures that final, active hormone. When the conversion step breaks down, your stored vitamin D can look perfectly fine while the hormone your cells actually respond to is dangerously low.

Calcitriol (1,25-dihydroxyvitamin D) is the body's most potent regulator of calcium balance. It tells your gut to absorb calcium from food, instructs your bones when to release or hold onto minerals, and signals your immune cells. Because it is so powerful, your body keeps it under tight hormonal control, which is exactly why this test reveals things about your kidneys, your parathyroid glands, and your mineral metabolism that a standard vitamin D level cannot.

What This Test Actually Measures

When you eat vitamin D or make it in your skin from sunlight, that raw material travels to the liver, where it gets a first chemical modification to become 25-hydroxyvitamin D, or 25(OH)D. That is what the standard vitamin D test (test code 67) measures. The 25(OH)D then travels to the kidneys, where an enzyme called 1-alpha-hydroxylase adds a second modification, turning it into 1,25-dihydroxyvitamin D, the molecule this test quantifies.

This distinction matters more than it might seem. Your body regulates 1,25(OH)₂D levels tightly through three hormonal signals: parathyroid hormone (PTH), which tells the kidneys to make more; fibroblast growth factor 23 (FGF-23), a hormone released by bone cells that tells the kidneys to make less; and blood levels of calcium and phosphorus themselves. Because of this tight regulation, your calcitriol level can look normal even when your vitamin D stores are low, and it can drop sharply when your kidneys are struggling, even if your stores are adequate.

Kidney Disease and Calcitriol

The most established clinical use of this test is in evaluating kidney health. As kidney function declines, the enzyme responsible for producing calcitriol becomes less active. In people with chronic kidney disease (CKD), calcitriol levels fall progressively. Dialysis patients average around 9.5 pg/mL, far below the 29 to 84 pg/mL range seen in healthy adults. This drop triggers a cascade: without enough calcitriol, your gut absorbs less calcium, your parathyroid glands ramp up PTH production to compensate, and your bones start losing mineral density. This chain of events, called secondary hyperparathyroidism, is one of the major complications of kidney disease.

If your calcitriol is low and your kidney function markers (eGFR or cystatin C) are also abnormal, the picture is straightforward: your kidneys are losing the ability to activate vitamin D. If calcitriol is low but kidney function appears normal, the cause may be vitamin D deficiency itself (too little raw material for the kidneys to convert), excessive FGF-23, or magnesium depletion. Each of these points to a different clinical path.

Bone and Mineral Health

Calcitriol is the gatekeeper of calcium absorption. Without adequate levels, you absorb only about 10 to 15% of dietary calcium. With healthy calcitriol levels, that number rises to 30 to 40%. Over time, chronically low calcitriol contributes to bone softening (osteomalacia in adults, rickets in children) and accelerates bone loss.

In a large cohort of over 500,000 adults, researchers proposed an optimal calcitriol range of 50 to 70 pg/mL. People whose levels fell below this window had higher rates of inflammation and disordered mineral metabolism, while levels above it were associated with conditions like granulomatous diseases (conditions where the immune system forms clusters of inflammatory cells, such as sarcoidosis) or overactive parathyroid glands. This range is a useful reference point, though it comes from a single large study and has not yet been adopted by major guideline bodies.

When Calcitriol Is Too High

An abnormally elevated calcitriol can be just as informative as a low one. Primary hyperparathyroidism, where one or more parathyroid glands become overactive, drives calcitriol production upward. In these cases, average levels reach around 82 pg/mL. Certain granulomatous diseases, including sarcoidosis (a condition where inflammatory cells accumulate in the lungs and other organs) and some lymphomas, produce calcitriol outside the kidneys in immune cells, bypassing normal regulation. This can cause dangerously high blood calcium. If your result comes back above the reference range, your next steps should include PTH, calcium, and phosphorus testing to identify the cause.

Immune Function

Immune cells carry their own version of the enzyme that converts 25(OH)D to calcitriol, meaning they produce calcitriol locally to regulate inflammation and pathogen defense. Most of the large-scale evidence linking vitamin D to infection risk and autoimmune disease comes from studies measuring 25(OH)D (the storage form, not this test's analyte). Whether circulating calcitriol measured in blood reflects these local immune actions is still an open question. A low calcitriol on this test does not necessarily mean your immune cells lack the active hormone they need, and a normal calcitriol does not guarantee they have enough.

Cardiovascular Associations

Some observational data suggest that low calcitriol levels track with higher cardiovascular risk, particularly in people with kidney disease. However, most of the major outcome studies linking vitamin D status to heart disease, stroke, and mortality measured 25(OH)D rather than 1,25(OH)₂D. Drawing direct conclusions about cardiovascular risk from a calcitriol level alone requires caution. The strongest signal is indirect: low calcitriol contributes to secondary hyperparathyroidism and disordered mineral metabolism, which in turn promote vascular calcification, a well-established driver of cardiovascular events in CKD.

Reference Ranges

Calcitriol reference ranges vary by lab and assay method, and the units are very small (picograms per milliliter). Two factors matter most when interpreting your result: the specific assay your lab used (different lab techniques can give somewhat different numbers), and your kidney function at the time of the draw. These ranges come from studies of healthy adults and a large observational cohort. They are orientation, not universal targets. Your lab may report slightly different cutpoints.

TierRange (pg/mL)What It Suggests
LowBelow 25Impaired kidney activation, severe vitamin D deficiency, or magnesium depletion. Warrants investigation with PTH, calcium, phosphorus, and kidney function tests.
Normal25 to 50Within the reference range for most healthy adults, but below the proposed optimal window.
Proposed Optimal50 to 70Associated with the lowest rates of inflammation and mineral metabolism imbalance in a large cohort study of over 500,000 adults.
ElevatedAbove 75 to 80May reflect hyperparathyroidism, granulomatous disease, or lymphoma. Requires evaluation of PTH and calcium.

Compare your results within the same lab over time for the most meaningful trend. A single reading in isolation is less informative than a direction of change.

When Results Can Be Misleading

Calcitriol has more confounders than most blood tests. The following situations can produce readings that do not reflect your true vitamin D hormone status:

  • Kidney function: Even a mild decline in kidney filtration rate (eGFR below about 60 mL/min) can lower calcitriol production. If your eGFR is not measured at the same time, a low calcitriol may be misattributed to vitamin D deficiency when the real issue is kidney impairment.
  • PTH status: If your parathyroid glands are overactive (which can happen silently for years), they push calcitriol higher. This can mask low vitamin D stores because PTH forces the kidneys to produce more calcitriol even when raw material is scarce.
  • Pregnancy: In the third trimester, calcitriol levels roughly double (averaging around 113 pg/mL) due to increased production by the placenta and kidneys. A result that looks dangerously high may be entirely normal in pregnancy.
  • Acute illness and inflammation: Critical illness, sepsis, and systemic inflammation can sharply reduce calcitriol levels. Testing during or shortly after a serious illness will give a misleadingly low result. Wait at least two to four weeks after recovery before testing.
  • SGLT2 inhibitor medications: Drugs like empagliflozin, dapagliflozin, and canagliflozin (used for diabetes and heart failure) lower calcitriol by roughly 10% through their effects on phosphorus and FGF-23 signaling. A modestly low calcitriol in someone taking these medications may reflect the drug's effect rather than a kidney or vitamin D problem.

Tracking Your Trend

A single calcitriol measurement is a snapshot of a tightly regulated hormone at one moment. Because PTH, FGF-23, calcium, and kidney function all shift calcitriol dynamically, a single reading can be misleading. Two readings three to six months apart, drawn under similar conditions (same time of day, same lab, similar health status), give you a trend that is far more useful than any individual number.

If you are making changes to your vitamin D supplementation, exercising more, or managing kidney disease, retest in three to six months to see if calcitriol is responding. For ongoing monitoring in CKD or hyperparathyroidism, every six months is reasonable. For healthy adults using this test as a deeper look at their vitamin D metabolism, an annual check alongside standard 25(OH)D is a practical cadence.

What to Do With Your Result

If your calcitriol is low (below 25 pg/mL), the first step is to check kidney function (eGFR and cystatin C), PTH, calcium, phosphorus, magnesium, and standard 25(OH)D at the same time. The pattern of these companion markers tells you where the problem is: low 25(OH)D with low calcitriol suggests insufficient raw material. Normal 25(OH)D with low calcitriol and reduced eGFR points to kidney-driven underproduction. Low calcitriol with high FGF-23 or low magnesium suggests a regulatory blockade.

If your calcitriol is elevated (above 75 to 80 pg/mL outside of pregnancy), check PTH, ionized calcium (the biologically active fraction of calcium in your blood), and phosphorus. High calcitriol with high PTH and high calcium points toward primary hyperparathyroidism, and an endocrinologist should be involved. High calcitriol with suppressed PTH raises concern for granulomatous disease or lymphoma and warrants further imaging and specialist evaluation.

If your result falls in the normal range and your kidney function is healthy, this test confirms that your body's vitamin D activation pathway is working. The standard 25(OH)D test remains the better tool for monitoring your overall vitamin D stores and guiding supplementation decisions. Think of calcitriol as the quality-control check on the activation step, not a replacement for the storage measurement.

What Moves This Biomarker

Evidence-backed interventions that affect your Calcitriol level

Increase
Take active vitamin D analogs (calcitriol or alfacalcidol) prescribed for kidney disease
In people with chronic kidney disease whose kidneys can no longer produce enough calcitriol on their own, taking the active hormone directly (oral calcitriol) or a precursor that bypasses the kidney step (alfacalcidol) raises circulating calcitriol levels and lowers PTH. This is the standard medical treatment for the secondary hyperparathyroidism that accompanies CKD. Because these medications bypass normal regulation, calcium levels must be monitored closely to avoid toxicity.
MedicationStrong Evidence
Increase
Engage in regular aerobic or resistance exercise training
Sustained exercise programs raise your calcitriol level, likely by increasing kidney blood flow and enzyme activity. In a randomized trial of a 12-week exercise program, calcitriol increased by roughly 11 to 14 pg/mL compared to sedentary controls. This represents a meaningful shift, especially if your baseline falls below the proposed optimal window of 50 to 70 pg/mL.
ExerciseModerate Evidence
Decrease
Take SGLT2 inhibitor medications (empagliflozin, dapagliflozin, canagliflozin)
SGLT2 inhibitors, commonly prescribed for type 2 diabetes and heart failure, lower calcitriol by roughly 10% by increasing phosphorus reabsorption, which raises FGF-23 and suppresses the kidney enzyme that makes calcitriol. If you are taking one of these medications, a modestly low calcitriol may reflect the drug's effect on mineral metabolism rather than a kidney or vitamin D problem. Whether this drop is clinically meaningful long-term is still being studied, but bone mineral density should be monitored in people on these medications.
MedicationModest Evidence
Increase
Take standard vitamin D3 (cholecalciferol) supplements
In people who are vitamin D deficient (low 25(OH)D stores), cholecalciferol supplementation provides more raw material for the kidneys to convert, which can modestly raise calcitriol. However, in people with adequate vitamin D stores and healthy kidneys, supplementation does not reliably increase calcitriol because the body's tight hormonal control keeps production steady regardless of how much raw material is available. This means you should not expect this test to change simply from adding a vitamin D supplement unless you were genuinely deficient to begin with.
SupplementModest Evidence

Frequently Asked Questions

References

10 studies
  1. Prevalence of Abnormal Serum Vitamin D, PTH, Calcium, and Phosphorus in Patients With Chronic Kidney Disease
    Levin aKidney International2007
  2. De Jong MAClinical Journal of the American Society of Nephrology2018